Recent 8-K filings for SXTP

• Feb 12, 2026 23:59 UTC regulatory materiality 0.60 positive item 8.01

  60 Degrees Pharmaceuticals regains Nasdaq compliance on minimum bid price; delisting hearing cancelled

  Received Nasdaq notice on Feb 11 confirming compliance with minimum bid price rule 5550(a)(2).

• Jan 23, 2026 23:59 UTC regulatory materiality 0.85 negative item 3.01item 7.01

  Nasdaq notifies 60 Degrees Pharmaceuticals of delisting for bid price rule violation

  Nasdaq determined common stock failed $1.00 minimum bid price for 30 consecutive business days.

• Jan 21, 2026 23:59 UTC other_material materiality 0.60 neutral item 5.03item 8.01item 9.01

  60 Degrees Pharmaceuticals to effect 1:4 reverse stock split effective Jan 20, 2026

  Reverse split at 1:4 ratio effective Jan 20, 2026 at 12:01 AM ET before market open.

• Jul 18, 2025 23:59 UTC other_material materiality 0.70 neutral item 1.01item 8.01item 9.01

  60 Deg Pharma closes $5M public offering, up to $10M with warrant exercise

  Gross proceeds $5M from sale of 2,631,578 units (share/pre-funded warrant + warrants) at $1.90/unit.

Executive changes

Materiality & sentiment trend

Max materiality 0.85 · Median 0.40 · Most common event other_material

1 positive 1 negative 10 neutral

source · SXTP on sec.gov